期刊文献+

三氧化二砷对系统性红斑狼疮患者外周血成熟和分化的影响 被引量:4

EFFECTS OF ARSENIC TRIOXIDE ON DIFFERETIATION AND MATURATION OF PERIPHERAL BLOOD DENDRITIC CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS
暂未订购
导出
摘要 目的:观察不同浓度三氧化二砷(ATO)对系统性红斑狼疮(SLE)患者外周血体外培养树突状细胞分化成熟和功能的影响,探讨其作用机制,初步阐明DC是否为ATO治疗SLE的作用靶点。方法:分离SLE患者外周血单个核细胞,用粒细胞巨噬细胞集落刺激因子(granulocyte macrophage colony stimulating factor,GM-CSF)、白细胞介素-4(interleukin-4,IL-4)细胞因子诱导DC成熟,加入不同浓度ATO培养。培养第9d收集DC细胞,流式细胞仪检测CD80、CD86和HLA-DR的表达。MTT法检测DC刺激淋巴细胞增殖的能力,ELISA法检测混和淋巴细胞反应培养上清IL-10和IFN-γ水平。结果:1.ATO处理后的DC表达CD80、CD86和HLA-DR百分数较对照组明显降低,P均<0.05,且随ATO浓度的增加DC表达CD80、CD86和HLA-DR百分数降低;2.ATO处理后的DC与T细胞混合培养,其刺激T细胞增殖相应的OD值较对照组明显降低,且随浓度增加降低越明显。3.其混合培养的上清液中IL-10水平较无ATO处理的DC与T细胞的混合培养上清液明显降低,P<0.05,而IFN-γ水平无统计学差异,P<0.05结论:ATO在体外可抑制SLE患者外周血DC的成熟,未成熟DC能抑制T细胞增殖及T细胞向Th2细胞转化,从而纠正SLE患者的部分免疫紊乱。 Objective:To detect the effects of different concentration of arsenic trioxide(ATO) on differention and maturation and function of peripheral blood dendritic cells(DCs) in SLE patients,and to explore its mechanism,clarifing whether the DC is the therapeutic targets to use ATO for SLE patients.Methods:The mononuclear cells were isolated from peripheral blood in SLE patients and developed into DCs by adding GM-CSF and IL-4.In ATO group,different concertrations of ATO was then added after adding the above cytokines.DCs were harvested after 9 days culture.CD80,CD86 and HLA-DR surface markers on DCs were detected by flow cytometry.MTT assay detects mixed lymphocyte reaction.IL-10 and IFN-γin the supernatant of MLR were detected by EL ISA. Results:1.The percentage of CD80 、CD86 and HLA-DR expression on the DCs treated with ATO were lower than those on the DCs without ATO-treated,all P0.05,and with the increasing of concertrations,the percentage of their reduction.2.The OD value related with T lymphocytes proliferation were lower in the MLR with the DCs treated with ATO than that in the MLR with the DCs without ATO treated,both P0.05,and with the increasing of concertrations,OD value was significantly lower.3.IL-10 level in the MLR supernatant of the group treated with ATO was lower than that in the control group,P0.05.but IFN-γlevel has no significant difference,P0.05).Conclusion:ATO can inhibit DCs maturation,and then the immature DCs can also inhibit T cells proliferation and refrain T cells from dividing into Th2 subtype in SLE patients.
出处 《牡丹江医学院学报》 2010年第6期18-23,共6页 Journal of Mudanjiang Medical University
基金 广西自然科学基金(桂自科0991136) 广西青年科学基金(桂科青0542055) 广西卫生厅重点课题(桂卫重200829) 广西卫生厅自筹课题(桂卫Z2001048)资助项目
关键词 三氧化二砷 系统性红斑狼疮 树突状细胞 Arsenic trioxide Systemic lupus erythematosus Dendritic cell
  • 相关文献

参考文献14

  • 1Foster MH.T cells and B cells in lupus nephritis[J].Semin Nephrol,2007,27(1):47-58.
  • 2Aringer M,.Bcl-2 protein in circulating T lymphocytes,but not B lymphocytes of patients with systemic lupus erythematosus[J].Arthritis Rheum,1994,37(10):1423-1430.
  • 3魏亚明,欧剑锋,欧英贤,白海,路继红,郑荣梁.三氧化二砷对白血病细胞凋亡和分化的双向诱导作用[J].西北国防医学杂志,2002,23(5):324-326. 被引量:9
  • 4Emlen W,Niebur J,Kadera R.Accelerated in vitro apoptosis of lymphocytes from patients with systemic Lupus erythematosus[J].Immunol,1994 Apr 1,152(7):3685-3692.
  • 5李晓华.系统性红斑狼疮中的细胞因子异常[J].上海免疫学杂志,1995,15(1):50-52. 被引量:10
  • 6周林福,周智敏,殷凯生.三氧化二砷对哮喘小鼠肺内树突状细胞的影响[J].江苏临床医学杂志,2002,6(4):298-301. 被引量:1
  • 7Banchereau J,V.Pascual,A.Palucka.Autoimmunity through cytokine-induced dendritic cell acactivation[J].Immunity,2004,20:539-550.
  • 8Van Voorhis WC,Valinsky J,Hoffman E,et al.Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication.J Exp Med,1983,158(1):174-191.
  • 9Tanaka H,Demeure CE,Rubio M,et al.Human monocyte -derived dendritic cells induce naive T cell differentiation into Thelper cell type 2 (Th2) or Th1/ Th2 effectors[J].Role of stimu2 lator/ responder ratio.J Exp Med,2000,192(3):405-412.
  • 10Yoshimura S,Bondeson J,Brennan FM,et al.Antigen presen2tation by murine dendritic cells is nuclear factor-kappa B de2pendent both in vitro and in vivo[J].Scand J Immunol,2003,58(2):165-172.

二级参考文献28

  • 1张鹏,王树叶,胡龙虎,施福东,邱凤琴,洪珞珈,韩雪英,杨惠芬,宋颖昭,刘艳平,周晋,金镇敬.三氧化二砷注射液治疗72例急性早幼粒细胞白血病[J].中华血液学杂志,1996,17(2):58-60. 被引量:478
  • 2[2]Drakesmith H, Chain B, Beverley P. How can dendritic cells cause autoimmune diease?[J] Immunol Today, 2000, 21(5): 214-217
  • 3[3]Rouard H, Leon A, Klonjkowski B, et al. Adenoviral transduction of human "clinical grade" immatyre dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity[J].J Immunol Meth, 2000, 241(1-2): 69-81.
  • 4[4]Dubois B, Catherine M, Beatice V, et al. Critical role of IL-12 in dendritic cell-induced differentiation of nasive B lymphocytes[J]. J Immunol, 1998, 161(5): 2223-2231.
  • 5[5]Blanco P, Palucha AK, Gill M, et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus [J].Science, 2001, 294(5546): 1540-1543.
  • 6方福德 杨焕明 等.分子生物学前言技术[M].北京:北京医科大学中国协和医科大学联合出版社,1998.370-420.
  • 7Dallal RM, Lotze MT. The dendritic cell and human cancer vaccines[J]. Curr. Opin. Immunol,2000, 12(5):583-588.
  • 8Banchereau J, Schuler-Thurner B, Palucka AK, et al. Dendritic cells as vectors for therapy[J]. Cell, 2001, 106(3):271-274.
  • 9Gatti E, Velleca MA, Biedermann BC et al. Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors[J]. J Immunol, 2000, 164(7):3600-3607.
  • 10Turley SJ, Steinman RM, Mellman I, et al. Propagation and culture of dendritic cells. In:lotzeMT Thomson AW.Dendritic Cells: Biology and Clinical Application[J]. San Diego,colif:Academic Press, 1999.544.

共引文献35

同被引文献51

  • 1方圣,曾凡钦.Toll样受体9与系统性红斑狼疮[J].国际皮肤性病学杂志,2006,32(6):356-358. 被引量:2
  • 2Foster M H.T cells and B cells in Lupus nephritis[J].Semin Nephrol,2007,27(1):47-58.
  • 3Bode P,Bonardelle D,Benihoud K,et al.Arsenic trioxide:a Promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/Lprmice[J].Blood,2006,108:3967-3975.
  • 4Amel-Kashipaz M R,Huqqins M L,Lanyon P,et al.Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-)and CD8(+) T cells in systemic lupus erythematosus[J].J Autoimmun,2001,17(2):155-163.
  • 5Grondal G,Traustadottir K H,Kristjansdottir H,et al.Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in icelandic systemic lupus erythematosus multicase families[J].Lupus,2002,11(7):435-442.
  • 6LLORENTE L,RICHAUD P Y,GARCIA P C,et al.Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systermic lupus erythematosus[J].Arthritis Rheum,2000,43(8):1790-1800.
  • 7Bob6 P, Chelbi-Alix MK. New therapeutic perspectives for Arsenic: from acute promyelocytic leukemia to autoimmuae diseases [J]. Med Sci (Paris), 2008, 24(11): 967-971.
  • 8Calder6n-Aranda ES, Vega L. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic [J]. FASEB J, 2006, 20(6):779-781.
  • 9Mak NK, Wong RNS, Leung KN, et al. Involvement of tumor necrosis factor (TNF-alpha) in arsenic trioxide induced apoptotic cell death of murine myeloid leukemia cells [J]. Toxicol Lett, 2002, 135( 1-2): 79-87.
  • 10Bobd P, Bonardelle D, Benihoud K, et al. Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice [J]. Blood, 2006, 108(13):3967-3975.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部